Skip to main content
PROF
NASDAQ Industrial Applications And Services

Profound Medical Pre-Announces Q3 Revenue of $9.8M-$10.0M, Beating Consensus by ~45-47%

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Medical Device Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$6.8
Mkt Cap
$207.505M
52W Low
$4.8
52W High
$8.95
52W Position info
42% above low
Off High info
24% below high
Rel. Volume info
2.4× avg
Market data snapshot near publication time

PROF sits 42% above its 52-week low of $4.8 on elevated volume (2.4× avg).

Summary

Profound Medical pre-announced Q3 2026 revenue of $9.8M-$10.0M, beating analyst consensus by ~45-47% and growing ~85-89% year-over-year, with gross margin above 70%.


Key Events · Earnings and Guidance · PROF

  • Q3 Revenue Beat by ~45-47%

    Preliminary Q3 2026 revenue of $9.8M-$10.0M versus Bloomberg consensus of $6.78M, representing 85-89% YoY growth from $5.3M in Q3 2025.

  • Sequential Growth of ~292-300%

    Revenue nearly quadrupled from $2.5M in Q2 2026, indicating a sharp inflection in TULSA-PRO commercial adoption.

  • Gross Margin Above 70%

    Management expects Q3 gross margin to again exceed 70%, reflecting operating leverage as revenue scales.

  • Full Results November 5, 2026

    Profound will report complete Q3 2026 financial results after market close on Thursday, November 5, 2026, with a conference call at 4:30 p.m. ET.


Analysis · PROF · Industrial Applications And Services

A sharp inflection in TULSA-PRO adoption is signaled by preliminary Q3 2026 revenue of $9.8 million to $10.0 million, roughly 45-47% above the Bloomberg consensus of $6.78 million. This represents a dramatic acceleration from Q2's $2.5 million — sequential growth of nearly 300% — and gross margin is expected to exceed 70%. The magnitude of the beat is substantial for a company with a $207 million market cap and quarterly revenue that was under $3 million just one quarter ago. The stock is likely to reprice on this news, as it suggests the commercial ramp is inflecting sharply.

How filings like this one have moved

In the 30 days to Oct 7, 2026, 29% of the 1648 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.62%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, PROF was trading at $6.80 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $207.5M. The 52-week trading range was $4.80 to $8.95. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

PROF - Latest Insights

PROF
Oct 07, 2026, 4:28 PM EDT
Source: Seeking Alpha
Importance Score:
7
Price at Filing: $6.00
Real-time Price: $6.66 info
Change: +$0.660 (+11%) info
Market Cap: $207.505M info
PROF
Aug 17, 2026, 7:30 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $6.60
Real-time Price: $6.66 info
Change: +$0.060 (+0.91%) info
Market Cap: $207.505M info
PROF
Aug 06, 2026, 4:32 PM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $7.94
Real-time Price: $6.66 info
Change: -$1.28 (-16%) info
Market Cap: $207.505M info
PROF
Aug 06, 2026, 4:20 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $7.94
Real-time Price: $6.66 info
Change: -$1.28 (-16%) info
Market Cap: $207.505M info
PROF
Jul 24, 2026, 11:58 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $7.00
Real-time Price: $6.66 info
Change: -$0.340 (-5%) info
Market Cap: $207.505M info